P2.123 Ropinirole prolonged release improves nocturnal symptoms in patients with advanced Parkinson's disease: an analysis of grouped items on the PDSS

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70474-2 ◽

2009 ◽

Vol 15 ◽

pp. S122-S123 ◽

Author(s):

K.R. Chaudhuri ◽

K. Sethi ◽

L. Giorgi ◽

K. Rolfe ◽

C.B. Rockett ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Prolonged Release ◽

Advanced Parkinson’S Disease

Download Full-text

A randomized, fixed-dose, dose–response study of ropinirole prolonged release in advanced Parkinson's disease

Neurodegenerative Disease Management ◽

10.2217/nmt-2016-0038 ◽

2017 ◽

Vol 7 (1) ◽

pp. 61-72 ◽

Author(s):

Theresa A Zesiewicz ◽

Stephen Chriscoe ◽

Theresa Jimenez ◽

James Upward ◽

Maria Davy ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dose Response ◽

Prolonged Release ◽

Advanced Parkinson’S Disease ◽

Dose Response Study

Download Full-text

An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson’s disease

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1005835 ◽

2015 ◽

Vol 31 (4) ◽

pp. 723-730 ◽

Author(s):

Zhenxin Zhang ◽

Jian Wang ◽

Xiaoying Zhang ◽

Shengdi Chen ◽

Zhenfu Wang ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Extension Study ◽

Prolonged Release ◽

Advanced Parkinson’S Disease ◽

Open Label Extension

Download Full-text

2.241 Relationship between awake time spent “off” and systemic exposure of ropinirole 24-hour prolonged release in patients with advanced Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70652-7 ◽

2007 ◽

Vol 13 ◽

pp. S109

Author(s):

D. Tompson ◽

R. Pahwa

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Systemic Exposure ◽

Prolonged Release ◽

Advanced Parkinson’S Disease

Download Full-text

2.238 Ropinirole 24-hour prolonged-release adjunctive therapy improves cardinal symptoms in patients with advanced Parkinson's disease not optimally controlled with L-dopa

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70649-7 ◽

2007 ◽

Vol 13 ◽

pp. S108

Author(s):

S. Isaacson ◽

R. Pahwa ◽

N. Earl

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adjunctive Therapy ◽

Prolonged Release ◽

Advanced Parkinson’S Disease ◽

Cardinal Symptoms

Download Full-text

P2.164 Ropinirole prolonged release maintains an increase in daily awake time spent “on” in patients with advanced Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70515-2 ◽

2009 ◽

Vol 15 ◽

pp. S134

Author(s):

F. Stocchi ◽

B. Hunter ◽

L. Giorgi ◽

B. Hersh

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Prolonged Release ◽

Advanced Parkinson’S Disease

Download Full-text

2.237 Ropinirole 24-hour prolonged release improves sleep disturbance, but does not increase daytime somnolence in patients with advanced Parkinson's disease when administered as adjunctive therapy

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70648-5 ◽

2007 ◽

Vol 13 ◽

pp. S108

Author(s):

S. Isaacson ◽

F. Stocchi ◽

N. Earl

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Sleep Disturbance ◽

Adjunctive Therapy ◽

Prolonged Release ◽

Daytime Somnolence ◽

Advanced Parkinson’S Disease

Download Full-text

P2.166 Once-daily ropinirole prolonged release improves activities of daily living and motor symptoms in patients with advanced Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70517-6 ◽

2009 ◽

Vol 15 ◽

pp. S135

Author(s):

F. Stocchi ◽

L. Giorgi ◽

K. Rolfe ◽

C.B. Rockett

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Activities Of Daily Living ◽

Daily Living ◽

Prolonged Release ◽

Motor Symptoms ◽

Advanced Parkinson’S Disease

Download Full-text

2.243 Ropinirole 24-hour prolonged release improves mood and quality of life in patients with advanced Parkinson's disease as adjunctive therapy

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70654-0 ◽

2007 ◽

Vol 13 ◽

pp. S109 ◽

Author(s):

F. Stocchi ◽

S. Isaacson ◽

H. Edin

Keyword(s):

Quality Of Life ◽

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adjunctive Therapy ◽

Prolonged Release ◽

Advanced Parkinson’S Disease

Download Full-text

P2.132 Long-term safety and patient preference for dose frequency in patients receiving ropinirole prolonged release in early or advanced Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(09)70483-3 ◽

2009 ◽

Vol 15 ◽

pp. S125

Author(s):

R.A. Hauser ◽

B. Hunter ◽

K. Rolfe ◽

L. Giorgi

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Patient Preference ◽

Prolonged Release ◽

Dose Frequency ◽

Advanced Parkinson’S Disease

Download Full-text

The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2013.07.009 ◽

2013 ◽

Vol 19 (11) ◽

pp. 1022-1026 ◽

Author(s):

Zhenxin Zhang ◽

Jian Wang ◽

Xiaoying Zhang ◽

Shengdi Chen ◽

Zhenfu Wang ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adjunctive Therapy ◽

Controlled Study ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Chinese Subjects

Download Full-text